Interview with Pierre Boyer, Servier Czech Republic
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
Address: SERVIER s.r.o., Praha City Center, Klimentská 46, 110 02, Prague,Czech Republic
Tel: +420 222 118 111
Servier started its activities in the Czech Republic in October of 1994. Throughout its years on the Czech pharmaceutical market, the company has built a strong position in the field of cardiology, diabetology, internal medicine, psychiatry and angiology. Servier’s drugs have been used by more than 800,000 Czech patients.
In 1998, Servier CZ established a research center for clinical development, based in Prague. The aim of the center is to organize clinical trials in accordance with Good Clinical Practice (GCP) and local laws.
In 2012, Servier ranked among the top five major pharmaceutical companies in the Czech Republic. The company has long been one of the most dynamic organizations in the Czech pharmaceutical market.
Innovative pharmaceutical products in the fields of cardiology, diabetology, internal medicine, psychiatry and angiology.
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
Martin Minarovič, Janssen’s country director Czech Republic, discusses the success factors behind the company’s strong growth, not only in terms of revenue but more importantly in terms of the number…
Ladislav Drož, CEO of APIGENEX, reveals the company’s strategy to survive after a leadership change and a reshuffling of the small-molecule science operations at their main client, Novo Nordisk. Drož…
Patrik Reichl, CEO of CzechInvest, the Investment and Business Development Agency under the Ministry of Industry and Trade of the Czech Republic, breaks down the role of the agency in…
Patrik Zachar, Vice President Central Europe of Ipsen, shares how the company has built a strong presence in oncology and neuroscience in the CE region and the Czech Republic, quickly…
In 1996, Jiří Žák, chairman & current CEO of FARMAK, took over the state-owned producer of vitamins FARMAKON where he previously worked for 30 years and turned it into a…
Milan Černek, country manager of Mylan in the Czech Republic, provides expert insights into current trends in the Czech Republic’s generics and biosimilars markets, describes the affiliate’s strategy to continue…
Kieran Leahy, general manager of Takeda in the Czech Republic and Slovakia, recounts how he has led the transformation of Takeda into a specialty care organization at the local level,…
Emelie Antoni joined AstraZeneca in Sweden 20 years ago, evolving in global, regional and local roles. Last year, she became country manager for Czech Republic & Slovakia, with an ambitious…
Robin Turner, general manager of Roche Czech Republic, shares how he transformed the affiliate from a “local” company to a highly engaged member of the Roche group whilst breaking down…
Increasing consolidation and digitalization within the Czech pharmacy sector is forcing consumer healthcare firms to rethink their strategies. Pharmacy Consolidation Within the Central and Eastern European (CEE) region, the…
Darina Hrdličková, chairwoman of the Association of Contract Research Organizations in the Czech Republic (ACRO-CZ), gives an overview of her new priorities and mission since taking over the position in…
Vladimír Velebný, founder and CEO, celebrates his 30th anniversary heading Contipro, a mid-sized company with deep experience in R&D surrounding their star product, hyaluronic acid. Whilst breaking down the components…
See our Cookie Privacy Policy Here